-+ 0.00%
-+ 0.00%
-+ 0.00%

Stifel Maintains Hold on Health Catalyst, Lowers Price Target to $2

Benzinga·03/13/2026 14:23:13
Listen to the news
Stifel analyst David Grossman maintains Health Catalyst (NASDAQ:HCAT) with a Hold and lowers the price target from $3.75 to $2.